|
|
Volumn 299, Issue 10, 2008, Pages 1121-1122
|
|
FDA warns of adverse events linked to smoking cessation drug and antiepileptics
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
ETIRACETAM;
FELBAMATE;
GABAPENTIN;
LAMOTRIGINE;
OXCARBAZEPINE;
PLACEBO;
PREGABALIN;
TIAGABINE;
TOPIRAMATE;
VALPROIC ACID;
VARENICLINE;
ZONISAMIDE;
BENZAZEPINE DERIVATIVE;
QUINOXALINE DERIVATIVE;
AGITATION;
BEHAVIOR CHANGE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
EPILEPSY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MENTAL DISEASE;
MIGRAINE;
MOOD DISORDER;
NEUROLOGIC DISEASE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SHORT SURVEY;
SIDE EFFECT;
SMOKING CESSATION;
SUICIDAL BEHAVIOR;
SUICIDAL IDEATION;
SUICIDE ATTEMPT;
UNSPECIFIED SIDE EFFECT;
NOTE;
RISK;
STATISTICS;
SUICIDE;
UNITED STATES;
ANTICONVULSANTS;
BENZAZEPINES;
HUMANS;
MENTAL DISORDERS;
QUINOXALINES;
RISK;
SMOKING CESSATION;
SUICIDE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 40749136302
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.299.10.1121 Document Type: Short Survey |
|
Times cited : (33)
|
|
References (0)
|